Sheraton Steamboat Resort Floorplan
Registered Attendees
Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:
- Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting
(You can edit your own abstract from My Account page as well)
NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.
- Full participant list, including joint meeting participants
- Printable Invoices and Invitation Letters
- Scholarship Information
- Lodging Information
Login to My Account page
This meeting took place in 2004
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
Biological Discovery Using Diverse High-Throughput Data (D5)
Organizer(s) David K. Gifford, Edward M. Rubin and Richard A. Young
March 30—April 4, 2004
Sheraton Steamboat Resort • Steamboat Springs, Colorado USA
Abstract Deadline: Dec 1, 2003
Late Abstract Deadline:
Scholarship Deadline:
Early Registration Deadline: Jan 30, 2004
Supported by Keystone Symposia
Summary of Meeting:
The meeting will explore the frontiers of biology and medicine from the perspective of genomes, transcriptomes, proteomes and other forms of global information. Its aim is to bring together investigators with interests in high-throughput interdisciplinary biomedical research. Diverse high-throughput technologies are providing information useful for understanding evolutionary processes, mapping regulatory networks, and developing new disease diagnostics and therapeutics. How these different high-throughput witnesses to cellular function can be merged to generate predictive models that improve our understanding of biology will be a key theme of the meeting. Upon completion of this conference, participants should be able to: -Identify the most exciting developments and challenges in genomics, proteomics and computational biology. -Discuss the emerging concepts and technologies that will be key to future high-throughput interdisciplinary biomedical research. -Learn how diverse high-throughput data can be optimally combined to develop predictive models of cellular and organism function. -Understand the successes and failures to date in applying high-throughput biology to normal and disease-related processes. -Discover how new technology and high-throughput information are generating new approaches to the development and use of diagnostics and therapeutics. -Explore and plan effective collaborations with biologists and computational experts who will be in attendance.
View Scholarships/Awards
The meeting will explore the frontiers of biology and medicine from the perspective of genomes, transcriptomes, proteomes and other forms of global information. Its aim is to bring together investigators with interests in high-throughput interdisciplinary biomedical research. Diverse high-throughput technologies are providing information useful for understanding evolutionary processes, mapping regulatory networks, and developing new disease diagnostics and therapeutics. How these different high-throughput witnesses to cellular function can be merged to generate predictive models that improve our understanding of biology will be a key theme of the meeting. Upon completion of this conference, participants should be able to: -Identify the most exciting developments and challenges in genomics, proteomics and computational biology. -Discuss the emerging concepts and technologies that will be key to future high-throughput interdisciplinary biomedical research. -Learn how diverse high-throughput data can be optimally combined to develop predictive models of cellular and organism function. -Understand the successes and failures to date in applying high-throughput biology to normal and disease-related processes. -Discover how new technology and high-throughput information are generating new approaches to the development and use of diagnostics and therapeutics. -Explore and plan effective collaborations with biologists and computational experts who will be in attendance.
View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference
TUESDAY, MARCH 30
WEDNESDAY, MARCH 31
THURSDAY, APRIL 1
FRIDAY, APRIL 2
SATURDAY, APRIL 3
SUNDAY, APRIL 4
Conference Program Print | View meeting in 12 hr (am/pm) time
TUESDAY, MARCH 30
19:30—20:30
Keynote Address
Meeting has ended...abstracts no longer viewable online.
Eric S. Lander,
Broad Institute, Massachusetts Institute of Technology, USA
Beyond the Human Genome
Beyond the Human Genome
08:00—11:00
Integrative Approaches to Sequence Analysis
Meeting has ended...abstracts no longer viewable online.
*
Svante Pääbo,
Max Planck Institute for Evolutionary Anthropology, Germany
Comparative Primate Genomics
Comparative Primate Genomics
Edward M. Rubin,
Lawrence Berkeley National Laboratory, USA
Trolling Vertebrate Evolution for Insights into the Annotation of the Human Genome
Trolling Vertebrate Evolution for Insights into the Annotation of the Human Genome
David Haussler,
University of California, Santa Cruz, USA
The Power of Multiple Vertebrate Genome Sequences
The Power of Multiple Vertebrate Genome Sequences
Ewan Birney,
Wellcome Trust Sanger Institute, UK
Ensembl as Genome Infrastrucure and Cis-Regulation in Vertebrates
Ensembl as Genome Infrastrucure and Cis-Regulation in Vertebrates
17:00—19:00
Regulation of Genome Expression
Meeting has ended...abstracts no longer viewable online.
Richard A. Young,
Whitehead Institute for Biomedical Research, USA
A Draft Transcriptional Regulatory Code for Yeast
A Draft Transcriptional Regulatory Code for Yeast
*
Martha L. Bulyk,
Brigham & Women's Hospital and Harvard Medical School, USA
Analysis of Yeast Transcription Factor DNA Binding Specificities Using in vitro Protein Binding Microarray (PBM) Experiments
Analysis of Yeast Transcription Factor DNA Binding Specificities Using in vitro Protein Binding Microarray (PBM) Experiments
Duncan Odom,
University of Cambridge, UK
Short Talk: Determining Transcriptional Regulatory Networks in Human Tissues
Short Talk: Determining Transcriptional Regulatory Networks in Human Tissues
Bing Ren,
Ludwig Institute for Cancer Research, USA
Short Talk: Mapping Transcriptional Regulatory Elements in Human DNA
Short Talk: Mapping Transcriptional Regulatory Elements in Human DNA
08:00—11:00
High-Throughput Analysis of Proteins and Cells
Meeting has ended...abstracts no longer viewable online.
Jack F. Greenblatt,
University of Toronto, Canada
Protein Complexes and Functional Pathways in Yeast
Protein Complexes and Functional Pathways in Yeast
Rudolf H. Aebersold,
Institute of Molecular Systems Biology, ETH Zürich, Switzerland
Quantitative Proteomics: Current Status, Challenges and New Directions
Quantitative Proteomics: Current Status, Challenges and New Directions
*
Erin K. O'Shea,
Harvard University, USA
High-Throughput Analysis of Subcellular Localization in Budding Yeast
High-Throughput Analysis of Subcellular Localization in Budding Yeast
Michael P. Snyder,
Stanford University School of Medicine, USA
Molecular, Cellular, Genetic and Genome Approaches to Study Cell Structure and Division
Molecular, Cellular, Genetic and Genome Approaches to Study Cell Structure and Division
17:00—19:00
Computational Fusion / Systems Biology I
Meeting has ended...abstracts no longer viewable online.
David K. Gifford,
Massachusetts Institute of Technology, USA
Transcriptional Regulatory Network Reconstruction with Complementary Data
Transcriptional Regulatory Network Reconstruction with Complementary Data
*
Daphne Koller,
Stanford University, USA
From Heterogeneous Data to Regulatory Models: A Probabilistic Approach
From Heterogeneous Data to Regulatory Models: A Probabilistic Approach
Dana Pe'er,
Memorial Sloan Kettering Cancer Center, USA
From Genome-Wide Data to Regulatory Programs: A Modular Approach
From Genome-Wide Data to Regulatory Programs: A Modular Approach
08:00—11:00
Computational Fusion / Systems Biology II
Meeting has ended...abstracts no longer viewable online.
*
Stuart K. Kim,
Stanford University Medical Center, USA
Global Analysis of Conserved Genetic Modules
Global Analysis of Conserved Genetic Modules
Thijn Brummelkamp,
Netherlands Cancer Institute, Netherlands
High-Throughput Loss-of-Function Genetic Screens in Mammalian Cells using RNA Interference
High-Throughput Loss-of-Function Genetic Screens in Mammalian Cells using RNA Interference
Michael Q. Zhang,
Cold Spring Harbor Laboratory, USA
Combinatorial Regulation of Transcriptional Gene Networks
Combinatorial Regulation of Transcriptional Gene Networks
17:00—19:00
Human Disease and High-Throughput Data
Meeting has ended...abstracts no longer viewable online.
*
Susan Lindquist,
HHMI/Whitehead Institute for Biomedical Research, USA
Proteins, Health and Disease
Proteins, Health and Disease
Kelly A. Frazer,
University of California, San Diego, USA
Whole Genome Haplotype Map of Humans
Whole Genome Haplotype Map of Humans
08:00—11:00
Diagnostics, Therapeutics and Pharmacogenomics
Meeting has ended...abstracts no longer viewable online.
Kathleen M. Giacomini,
University of California, San Francisco, USA
Pharmacogenomics of Membrane Transporters
Pharmacogenomics of Membrane Transporters
17:00—19:00
Emerging Concepts and Technologies
Meeting has ended...abstracts no longer viewable online.
*
Leroy E. Hood,
Institute for Systems Biology, USA
Systems Approaches to Development and Physiology
Systems Approaches to Development and Physiology
Michael Boutros,
German Cancer Research Center, Germany
Short Talk: Genome-Wide Cell based RNAi Screens in Drosophila
Short Talk: Genome-Wide Cell based RNAi Screens in Drosophila
*Session Chair †Invited, not yet responded.
We gratefully acknowledge support for this conference from:
We gratefully acknowledge the generous grant for this conference provided by:
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
|
If your organization is interested in joining these entities in support of Keystone
Symposia, please contact: Sarah Lavicka,
Director of Development, Email: sarahl@keystonesymposia.org, Phone:+1 970-262-2690 Click here for more information on Industry Support and Recognition Opportunities. If you are interested in becoming an advertising/marketing in-kind partner, please contact: Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org, Phone:+1 970-262-2676 |
